The team of Anne-Marie Mes-Masson, researcher at the Montreal Cancer Institute, is one of the winning teams of the LeadAction competition | Breast Cancer du Sein.
Their research project entitled “Development of small molecule inhibitors of GTPase Ran as anticancer agents” is based on the discoveries made with Dr. Diane Provencher in cancer of the ovary. The funded study extends this discovery to breast cancer and therefore allows for a new collaboration with Dr. Saima Hassan, one of our young researchers at the Institute. A great story of collaboration and continuity! Congratulations to the entire Anne-Marie Mes-Masson team for this great accomplishment!
Thomas Gervais’ Discovery Named One of Québec Science’s Top 10 of 2021
18 January 2022
Research member Thomas Gervais, a full professor in the Department of Engineering Physics at Polytechnique Montreal, and his team have […]
BERTRAND ROUTY, WINNER OF THE PRIX RELÈVE SCIENTIFIQUE
3 November 2022
Congratulations to Dr. Bertrand Routy, a research fellow of the Institut du cancer de Montréal, who, as part of the […]